ArticleJAMA network open2021

Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China.

Yuan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.